Cheng, R. , Liu, J. , Hao, L. and Wu, D. (2026) On the Application of the Infinitesimal Method to Two Categories of Problems in College Physics. Open Journal of Social Sciences, 14, 378-389. doi: ...
UW-Madison researchers have found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of less than a year. The research involved thousands of fruit ...
Researchers have used a cutting-edge robotic system capable of synthesizing hundreds of metal complexes to develop a possible antibiotic candidate—offering fresh hope in the global fight against ...
It has not always been smooth sailing for the North Carolina Tar Heels' offensive production this season, but the team has identified a way to generate consistent points. During the last two weeks, ...
U.S. pay-TV subscriber levels posted their first increase since 2017 during the third quarter, according to a new report from Wall Street research firm Moffett Nathanson. Overall subscriptions to ...
Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. As we enter the final week of the ...
AppLovin's AI-powered advertising platform has delivered over 4,000% returns in three years. CrowdStrike has bounced back strongly from its July 2024 incident as customers stayed loyal to its ...
The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.
It was all treats and no tricks on Tuesday's Halloween episode of "High Potential," which ended with the only thing better than a candy haul — we finally got a peek inside Roman's backpack! At the top ...
Rates on 30-year mortgages fell again this week to an average of 6.27%, according to Freddie Mac. That could boost consumer spending on home improvements in 2026, new research finds. Jaime Katz ...
Arcus Biosciences boasts a diverse, promising pipeline with key candidates like domvanalimab, casdatifan, and quemliclustat advancing in pivotal trials. Recent data from RCUS's EDGE-Gastric trial show ...